Experimental photodynamic therapy with meso-tetrakisphenylporphyrin (TPP) in liposomes leads to disintegration of human amelanotic melanoma implanted to nude mice

International Journal of Cancer

Volumn 103, Issue 5, 2003, Pages 693-702

  Ježek, Petr ^a   Nekvasil, Milos ^a   Škobisová, Eva ^a   Urbánková, Eva ^a   Jirsa, Milan ^b   Zadinová, Marie ^b   Poučková, Pavla ^b   Klepáček, Ivo ^b  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Human amelanotic melanoma; Liposomal drug delivery; Meso tetrakis sulfonatophenylporphyrin; Meso tetrakis phenylporphyrin; Nude mice; Photodynamic therapy

Indexed keywords

HEMATOPORPHYRIN DERIVATIVE; LIPOSOME; MESO TETRAKISPHENYLPORPHYRIN; PHOTOSENSITIZING AGENT; TETRAPHENYLPORPHYRIN DERIVATIVE; UNCLASSIFIED DRUG;

AMELANOTIC MELANOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER REGRESSION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FEMALE; LIGHT EXPOSURE; MOUSE; NONHUMAN; NUDE MOUSE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TIME SERIES ANALYSIS; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; DRUG CARRIERS; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; INJECTIONS, INTRAVENOUS; LIPOSOMES; MELANOMA, AMELANOTIC; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SKIN NEOPLASMS;

EID: 0037455837     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10857     Document Type: Article

References (35)

1. Henderson BW, Waldow SM, Mang TS, Potter WR, Malone PB, Dougherty TJ. Tumour destruction and kinetics of tumour cell death in two experimental mouse tumours following photodynamic therapy. Cancer Res 1985;45:572-6.
2. Zhou C. Mechanisms of tumour necrosis induced by photodynamic therapy. J Photochem Photobiol B Biol 1989;3:299-318.
3. Fingar VH, Wieman TJ, Doak KW. Mechanistic studies of PDT-induced vascular damage: evidence that eicosanoids mediate this process. Int J Radiat Biol 1991;60:303-9.
4. Jori G, Reddi E. Strategies for tumour targeting by photodynamic sensitizers, In: Kessel D, ed. Photodynamic therapy of neoplastic disease. Boca Raton: CRC Press, 1990. 117-130.
5. Jori G, Beltramini M, Reddi E, Pagnan A, Tomio L, Tsanov T. Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo. Cancer Lett 1990;24:291-7.
6. Polo L, Valduga G, Jori G, Reddi E. Low-density lipoprotein receptors in the uptake of tumour photosensitizers by human and rat transformed fibroblasts. Int J Biochem Cell Biol 2002;34:10-23.
7. Reyftmann JP, Moliere P, Goldstein S, Santus R, Dubetret L, Lagrange D. Interaction of human serum low density lipoproteins with porphyrins - a spectroscopic and photochemical study. Photochem Photobiol 1984;40:721-9.
8. Maziere JC, Santus R, Morliere P, Reyftmann JP, Candide C, Mora L, Salmon S, Maziere C, Gatt S, Dubetret L. Cellular uptake and photosensitizing properties of anticancer porphyrins in cell membranes and low and high density lipoproteins. J Photochem Photobiol B Biol 1990;6:61-8.
9. Hwang KJ, Padki MM, Chow DD, Essien HE, Lai JY, Beaumier PL. Uptake of small liposomes by nonreticuloendothelial tissues. Biochim Biophys Acta 1987;901:88-96.
10. Jori G, Tomio L, Reddi E, Rossi E, Corti E, Zorat PL, Calzavara F. Preferential delivery of liposome-incorporated porphyrins to neoplastic cells in tumour bearing rats. Br J Cancer 1983;48:307-9.
11. Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumours. Proc Natl Acad Sci USA 1998;85:6949-53.
12. Gabizon A, Price DC, Huberty J, Bresalier RS, Papahadjopoulos D. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumours: biodistribution and imaging studies. Cancer Res 1990;50:6371-8.
13. Henderson BW, Mayhew E. Experience with the liposomal delivery of the photosensitizer isoBoSiNc, in photodynamic therapy: mechanisms II. Proc SPIE 1990;1203:126-35.
14. Reddi E, Zhou C, Biolo R, Menegaldo E, Jori G. Liposome- or LDL-administered Zn(II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency. Br J Cancer 1990;61:407-11.
15. Ginevra F, Biffanti S, Pagnan A, Biolo R, Reddi E, Jori G. Delivery of the tumour photosensitizer zinc(II)-phthalocyanine to serum proteins by different liposomes: studies in vitro and in vivo. Cancer Lett 1990;49:59-65.
16. Cuomo VG, Jori G, Rihter B, Kenney ME, Rodgers MAJ. Liposome-delivered Si(IV)-naphtalocyanine as a photodynamic sensitizer for experimental tumours: pharmacokinetics and phototherapeutic studies. Br J Cancer 1991;62:966-70.
17. Richter AM, Waterfield E, Jain AK, Canaan AJ, Allison BA, Levy JG. Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring (BPD), to tumor tissue in a mouse tumor model. Photochem Photobiol 1993;57:1000-6.
18. Love WG, Duk S, Biolo R, Jori G, Taylor PW. Liposome-mediated delivery of photosensitizers: localization of zinc (II)-phthalocyanine within implanted tumours after intrevenous administration. Photochem Photobiol 1996;63:656-61.
19. Jiang F, Lilge L, Logie B, Li Y, Chopp M. Photodynamic therapy of 9L gliosarcoma with liposome-delivered Photophrin. Photochem Photobiol 1997;65:701-6.
20. Wöhrle D, Muller S, Shopova M, Mantareva V, Spassova G, Vietri F, Ricchelli F, Jori G. Effect of delivery system on the pharmacokinetic and phototherapeutic properties of bis(methyloxyethyleneoxy)siliconphthalocyanine in tumour-bearing mice. J Photochem Photobiol B Biol 1999;50:124-8.
21. Faustino MAF, Neves MGPMS, Vicente MGH, Cavaleiro JAS, Neumann M, Brauer H-D, Jori G. Meso-tetraphenylporphyrin dimer derivative as a potential photosensitizer in photodynamic therapy. Photochem Photobiol 1997;66:405-12.
22. Faustino MAF, Neves MGPMS, Cavaleiro JAS, Neumann M, Brauer H-D, Jori G. Part 2. meso-tetraphenylporphyrin dimer derivatives as a potential photosensitizer in photodynamic therapy. Photochem Photobiol 2000;72:217-25.
23. Winkelman J. The distribution of tetraphenylporphine - sulfonate in the tumour-bearing rat. Cancer Res 1962;22:589-96.
24. Sima AAF, Kennedy JC, Blakeslee D, Robertson DM. Experimental porphyric neuropathy. A preliminary report. J Canad Sci Neurol 1981;8:105-14.
25. Jirsa M Jr, Poučková P, Doležal J, Pospíšil J, Jirsa M. Hyperbaric oxygen and photodynamic therapy in tumour-bearing nude mice. Eur J Cancer 1991;27:109.
26. 4). J Photochem Photobiol B Biol 1996;36:205-7.
27. Lovčinský M, Borecký J, Kubát P, Ježek P. Meso-tetraphenylporphyrin in liposomes as a suitable photosensitizer for photodynamic therapy of tumors. Gen Physiol Biophys 1999;18:107-18.
28. Cañete M, Villanueva A, Domínguez V, Polo S, Juarranz A, Stockert JC. Meso-tetraphenylporphyrin: photosensitizing properties and cytotoxic effects on cultured tumor cells. Int J Oncol 1998;13:497-504.
29. Macdonald RC, Macdonald RI, Menco BPM, Takeshita K, Subbarao NK, Hu L-R. Small-volume extrusion apparatus for preparation of large unilamellar vesicles. Biochim Biophys Acta 1991;1061:297303.
30. Moša M, Zitko M, Poučková P. Distribution and photodynamic effect of zinc phthalocyanine disulfonate in nude mice bearing mammary carcinoma. Neoplasma 1997;44:178-83.
31. Inaba M, Tazuko T, Fujimoto S, Sakurai MK, Ohnishi Y, Ueyyama Y, Nomura T. Evaluation of response rates to various antitumour agents of human gastric tumours implanted in nude mice. Jap J Cancer Res 1986;77:190-6.
32. Poučková, P. Ph.D. thesis, Charles University, 1st Medical Faculty, 1990.
33. Zee-Cheng RK, Cheng CC. Delivery of anticancer drugs. Meth Find Exp Clin Pharmacol 1989;11:439-529.
34. Renade VV. Drug delivery systems. I. site-specific drug delivery using liposomes as carriers. J Clin Pharmacol 1989;29:685-94.
35. Oku N, Saito N, Namba Y, Tsukada H, Dolphin D, Okada S. Application of long-circulating liposomes to cancer photodynamic therapy. Biol Pharm Bull 1997;20:670-3.